Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Sims DJ"'
Autor:
Poudel KK; Community Health Campaign Bharatpur, Nepal., Singh D; Early Detection, Prevention and Infection Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France., Sims DJ; Faculty of Health, University Technology Sydney, Australia.
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Oct 01; Vol. 25 (10), pp. 3635-3642. Date of Electronic Publication: 2024 Oct 01.
Autor:
O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA. peter.odwyer@pennmedicine.upenn.edu., Gray RJ; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Li S; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Wang V; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Iafrate AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sklar J; Yale University, New Haven, CT, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Coffey B; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA., Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Hamilton SR; City of Hope National Medical Center, Duarte, CA, USA., Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1349-1357. Date of Electronic Publication: 2023 Jun 15.
© 2018 John Wiley & Sons Ltd Aims and objectives: To describe experienced child and family health nurses’ clinical decision-making during a postnatal psychosocial assessment. Background: Maternal emotional well-being in the postnatal year optimise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::ac8de5f0e1592475014c1785b762fced
https://hdl.handle.net/10453/129491
https://hdl.handle.net/10453/129491
Autor:
Flaherty KT; Massachusetts General Hospital, Boston, MA., Gray RJ; ECOG-ACRIN Cancer Research Group Biostatistics Center, Dana Farber Cancer Institute Boston, MA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Li S; ECOG-ACRIN Cancer Research Group Biostatistics Center, Dana Farber Cancer Institute Boston, MA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Patton D; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Iafrate AJ; Massachusetts General Hospital, Boston, MA.; Harvard University, Boston, MA., Sklar J; Yale University, New Haven, CT., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD., Coffey B; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD., Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX., Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, TX., Comis R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA.; Deceased., Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., O'Dwyer PJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 20; Vol. 38 (33), pp. 3883-3894. Date of Electronic Publication: 2020 Oct 13.
Autor:
Flaherty KT; Massachusetts General Hospital, Boston, MA, USA., Gray R; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Li S; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA., Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Iafrate AJ; Massachusetts General Hospital, Harvard University, Boston, MA, USA., Sklar J; Yale University, New Haven, CT, USA., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Coffey B; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Catalano R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Magnan R; ECOG-ACRIN Cancer Research Group, Boston, MA, USA., Kibbe W; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA., Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Alexander B; Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Kumar S; Mayo Clinic, Rochester, MN, USA., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lih CJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., McCaskill-Stevens W; Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA., Caimi P; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Datta V; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, TX, USA., Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Comis R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Oct 01; Vol. 112 (10), pp. 1021-1029.
Autor:
Minooee S; Centre for Midwifery, Child and Family Health, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia., Cummins A; Centre for Midwifery, Child and Family Health, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia., Sims DJ; Centre for Midwifery, Child and Family Health, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia., Foureur M; Hunter New England Nursing and Midwifery Research Centre & University of Newcastle, Newcastle, New South Wales, Australia., Travaglia J; Centre for Health Services Management, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
Publikováno v:
Journal of evaluation in clinical practice [J Eval Clin Pract] 2020 Aug; Vol. 26 (4), pp. 1270-1279. Date of Electronic Publication: 2019 Dec 10.
Autor:
Kodama, Hiroaki1 (AUTHOR), Murakami, Haruyasu1 (AUTHOR) ha.murakami@scchr.jp, Mamesaya, Nobuaki1 (AUTHOR), Kobayashi, Haruki1 (AUTHOR), Omori, Shota2 (AUTHOR), Wakuda, Kazushige1 (AUTHOR), Ko, Ryo1 (AUTHOR), Ono, Akira1 (AUTHOR), Kenmotsu, Hirotsugu1 (AUTHOR), Naito, Tateaki1 (AUTHOR), Matsumoto, Shingo3 (AUTHOR), Goto, Koichi3 (AUTHOR), Shimizu, Tetsuo4 (AUTHOR), Gon, Yasuhiro4 (AUTHOR), Takahashi, Toshiaki1 (AUTHOR)
Publikováno v:
Thoracic Cancer. Jul2024, Vol. 15 Issue 21, p1665-1672. 8p.
Autor:
Sims DJ; Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia., Fowler C; Faculty of Health, Tresillian Chair in Child and Family Health, University of Technology Sydney, Ultimo, NSW, Australia.
Publikováno v:
Journal of clinical nursing [J Clin Nurs] 2018 Oct; Vol. 27 (19-20), pp. 3739-3749. Date of Electronic Publication: 2018 Jul 23.
Autor:
Baas, Melanie A.M.1,2 (AUTHOR), Stramrood, Claire A.I.1,3 (AUTHOR), Molenaar, Jolijn E.1 (AUTHOR), van Baar, Petra M.1,4 (AUTHOR), Vanhommerig, Joost W.5 (AUTHOR), van Pampus, Maria G.1 (AUTHOR) m.g.vanpampus@olvg.nl
Publikováno v:
BMC Psychiatry. 4/16/2024, Vol. 24 Issue 1, p1-10. 10p.
Autor:
Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Datta V; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Yau J; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Singh RR; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Routbort MJ; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mantha GS; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Krishnamurthy S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ronski K; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Walther Z; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Finberg KE; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Canosa S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Robinson H; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Raymond A; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Le LP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Sklar JL; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Hamilton SR; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: mickey.williams@nih.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2017 Mar; Vol. 19 (2), pp. 313-327. Date of Electronic Publication: 2017 Feb 07.